Background: Frontotemporal lobar degeneration (FTLD)- TAR DNA-binding protein 43 (TDP) type C is commonly associated with a clinical diagnosis of semantic dementia (SD). Although anterior temporal lobe (ATL) is one of the primary atrophy centers, it is yet to be defined which other areas are involved in the TDP-type C pathology early in the disease course.
Methods: We included 16 patients with autopsy-confirmed FTLD-TDP type C from the database of the UCSF Memory and Aging Center: 13 patients with semantic variant primary progressive aphasia (svPPA) and predominant left ATL atrophy, and 3 patients with semantic behavioral variant frontotemporal dementia (sbvFTD) and predominant right ATL atrophy. The inclusion criteria required a high-resolution T1-weighted MRI scan within four years of disease onset, a Mini-Mental Status Examination (MMSE) score ≥ 21, clinical dementia rating (CDR) ≤ 1 and CDR-sum of boxes (SOB) ≤ 9. We employed voxel-based morphometry (VBM) in SPM12 to identify regions of significant atrophy comparing the SD patients to a group of healthy controls (HC) (N = 29, Mean age 67+6, female = 19). Additionally, we developed a composite neurodegeneration score by summing the neuron loss scores with the mean values of astrogliosis and microvacuolation, as assessed by a neuropathologist.
Results: Voxel-based morphometry (VBM) analysis comparing SD patients to healthy controls revealed greatest atrophy in the left temporal pole, with subsequent involvement of the left amygdala, entorhinal area, fusiform gyrus, parahippocampal area, and inferior temporal gyrus (ITG). Conversely, the lingual gyrus and inferior occipital area followed by right postcentral, precentral, and angular gyri exhibited the least volume loss. These imaging findings align with autopsy results, indicating that areas with the highest and least volume loss correspond to regions with greater and lower neurodegenerative changes, respectively.
Conclusions: Our results highlighted the potential trajectory of TDP-type C pathology over the disease course which likely originates in the ATL and extends posteriorly and inferiorly to affect the ITG and parahippocampal regions. The progression pattern suggests that sensorimotor centers and the angular gyrus, as well as the regions associated with primary visual processing, tend to be compromised in the later stages of the disease based on both imaging and neuropathological findings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.093527 | DOI Listing |
Alzheimers Dement
December 2024
Memory & Aging Center, Department of Neurology, University of California in San Francisco, San Francisco, CA, USA.
Background: Frontotemporal lobar degeneration (FTLD)- TAR DNA-binding protein 43 (TDP) type C is commonly associated with a clinical diagnosis of semantic dementia (SD). Although anterior temporal lobe (ATL) is one of the primary atrophy centers, it is yet to be defined which other areas are involved in the TDP-type C pathology early in the disease course.
Methods: We included 16 patients with autopsy-confirmed FTLD-TDP type C from the database of the UCSF Memory and Aging Center: 13 patients with semantic variant primary progressive aphasia (svPPA) and predominant left ATL atrophy, and 3 patients with semantic behavioral variant frontotemporal dementia (sbvFTD) and predominant right ATL atrophy.
Alzheimers Dement
December 2024
Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
Background: There is considerable variability in the rate of clinical progression among individuals with frontotemporal dementia (FTD) and prognostic markers are lacking. Moreover, due to the rarity of postmortem data, the relationship between rate of progression and postmortem tau and TDP-43 proteinopathy is understudied.
Method: To explore the pathologic underpinnings of differences in clinical progression of FTD, we used clinical data collected by the Penn Center for Neurodegenerative Disease Research from 130 patients with autopsy-confirmed frontotemporal lobar degeneration (FTLD-tau = 62, FTLD-TDP = 68) across six domains (age at onset, survival in years, first Clinical Dementia Rating [CDR] scale score, first Mini-Mental State Examination [MMSE] score, annual change in CDR, annual change in MMSE).
Nature
October 2024
MRC Laboratory of Molecular Biology, Cambridge, UK.
Neurodegenerative diseases are characterized by the abnormal filamentous assembly of specific proteins in the central nervous system. Human genetic studies have established a causal role for protein assembly in neurodegeneration. However, the underlying molecular mechanisms remain largely unknown, which is limiting progress in developing clinical tools for these diseases.
View Article and Find Full Text PDFActa Neuropathol
June 2024
Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute On Aging, Perelman School of Medicine, University of Pennsylvania, 613A Stellar Chance Laboratories, 422 Curie Blvd, Philadelphia, PA, 19104, USA.
TAR DNA-binding protein 43 (TDP-43) is an RNA binding protein found within ribonucleoprotein granules tethered to lysosomes via annexin A11. TDP-43 protein forms inclusions in many neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and limbic predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC). Annexin A11 is also known to form aggregates in ALS cases with pathogenic variants in ANXA11.
View Article and Find Full Text PDFJ Neuropathol Exp Neurol
August 2024
Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, Shaanxi, P.R. China.
The RNA/DNA-binding protein TDP-43 plays a pivotal role in the ubiquitinated inclusions characteristic of TDP-43 proteinopathies, including most cases of frontotemporal lobar degeneration (FTLD-TDP) and Alzheimer disease (AD). To understand the mechanisms of pathological TDP-43 processing and identify potential biomarkers, we generated novel phosphorylation-independent monoclonal antibodies (MAbs) using bacteria-expressed human full-length recombinant TDP-43. Remarkably, we identified a distinctive MAb, No.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!